Educational article
Altered PBPs and resistance
Penicillin-binding proteins, PBPs, participate in cell-wall assembly. Lower affinity for β-lactams can reduce susceptibility without enzymatic antibiotic destruction. This differs from a β-lactamase mechanism, although…
Overview
Penicillin-binding proteins, PBPs, participate in cell-wall assembly. Lower affinity for β-lactams can reduce susceptibility without enzymatic antibiotic destruction. This differs from a β-lactamase mechanism, although both can coexist.
Biology and practical meaning
MRSA involves mec-associated target changes, whereas pneumococci have other PBP changes. Organism-specific screening and inference rules differ. A staphylococcal methicillin-resistance test cannot be transferred to all Gram-positive bacteria or every newer β-lactam.
Connecting gene, mechanism and phenotype
A genetic determinant, activity of its product and the measured phenotype are connected levels, not a single result. Permeability, efflux, enzymes and target changes can contribute simultaneously. Their effects depend on species, genetic background and expression.
A positive gene assay confirms its specified target in the tested material. In a mixed specimen, the gene’s connection to a particular organism may remain uncertain. A negative result is limited by the panel and assay characteristics; it cannot exclude unknown mechanisms or targets outside the panel.
Reports should retain the method, gene or family, AST findings and interpretive standard. Discordance calls for assessment of quality and context rather than selecting the convenient answer. The same gene in two patients does not prove direct transmission: genetic surroundings and epidemiological evidence matter. A mechanism helps explain biology and guide confirmation, but does not provide the entire susceptibility profile or independently determine treatment.
Sources
Read next
Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.